Baylor College of Medicine

Study of Miricorilant in Obese Adults with Schizophrenia or Bipolar Disorder and Recent Weight Gain While Taking Antipsychotics (GRATITUDE II) (H-49885)

Description

Content

Volunteers Needed for a Research Study on Weight Gain Associated with Schizophrenia Medications

You may qualify if you are between 18 and 65 years old and have gained weight from taking one of the following medications to treat your schizophrenia:

  • Olanzapine (Zyprexa)
  • Risperidone (Risperdal)
  • Paliperidone (Invega)
  • Quetiapine (Seroquel)

If so, consider joining GRATITTUDE II, a randomized, placebo-controlled research study of an investigational drug that may help you lose weight while taking an antipsychotic medication.

Qualified participants can expect the following during the 34-week study:

  • Attend study clinic visits regularly to receive assessments
  • Take the study drug or placebo (a “dummy” study drug) daily for 26 weeks

Potential benefits for qualified participants:

  • Study-related laboratory tests and no-cost health examinations
  • Education about diet and exercise habits

You may receive compensation for your time and travel. 

Contact

Uzma Khalid

Phone 1: 346–266–8167

IRB: H-49885

Status:

Active

Created:

Back to topback-to-top